KKR to Acquire Integer Holdings at $127 Per Share

Private equity giant KKR has signed an agreement to acquire medical technology company Integer Holdings for $127 per share in cash. The offer represents a premium of approximately 20% over Integer Holdings' last closing price. The total value of the deal is estimated at around $4.5 billion. Integer Holdings specializes in manufacturing critical components used in medical devices such as pacemakers and neurostimulation devices. The company has drawn attention in recent years for its strong growth in the medical technology sector. KKR aims to expand its healthcare portfolio and strengthen its position in the medical device market through this acquisition. The deal has been unanimously approved by the boards of directors of both companies. The transaction is expected to close in the first half of 2025, subject to customary conditions, including regulatory approvals and the approval of Integer Holdings shareholders. KKR will finance the acquisition using existing funds and new credit facilities. Integer Holdings' CEO stated that this agreement will accelerate the company's growth strategy and enable better service to customers. In a statement from KKR, it was emphasized that Integer Holdings' innovative product portfolio and strong customer relationships, combined with KKR's healthcare expertise, will create significant value. This acquisition stands out as one of KKR's largest recent investments in the healthcare sector. Experts note that such mergers and acquisitions could accelerate consolidation in the medical technology field and increase competition in the industry. Upon completion of the deal, Integer Holdings shares are expected to be delisted from the New York Stock Exchange. This is not investment advice.